When combined with diet and exercise, semaglutide aids in maintaining a healthy weight
Current evidence does not support a consistent primary impairment of basic gustatory function during GLP-1RA treatment
Attend A&E or call 999 if you experience persistent vomiting preventing fluid intake, severe abdominal pain (especially radiating to the back), signs of dehydration, upper right abdominal pain with fever or jaundice, or inability to tolerate food or fluids for more than 24 hours
While ketone bodies can inhibit approximately 40 percent of natural GLP-1 secretion through the FFAR3 receptor, this does not affect the synthetic GLP-1 receptor agonists you take as medication
NHS-Recommended Alternatives for Weight Management MHRA-licensed options include orlistat, semaglutide (Wegovy, NICE TA875), and liraglutide (Saxenda, NICE TA664), all used alongside lifestyle changes within appropriate NHS services